Avadis Tevanian, Director at Dolby Laboratories, Inc. (DLB), sold 3,950 shares at $31.80 ($126K) on 2013-02-07, disclosed to the SEC on 2013-02-08.
Scheduled sale ($126k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DLB | SELL | 2021-02-04 | $163K | — | Filing → |
| DLB | SELL | 2020-02-06 | $282K | — | Filing → |
| DLB | SELL | 2019-02-06 | $127K | — | Filing → |